See more : Amerant Bancorp Inc. (AMTB) Income Statement Analysis – Financial Results
Complete financial analysis of Huadong Medicine Co., Ltd (000963.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Huadong Medicine Co., Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Anxo Pharmaceutical Co., Ltd. (6677.TWO) Income Statement Analysis – Financial Results
- Wildsky Resources Inc. (HWTHF) Income Statement Analysis – Financial Results
- Lexibook – Linguistic Electronic System Société anonyme (ALLEX.PA) Income Statement Analysis – Financial Results
- Ccoop Group Co., Ltd (000564.SZ) Income Statement Analysis – Financial Results
- JTNB Bancorp, Inc. (JTNB) Income Statement Analysis – Financial Results
Huadong Medicine Co., Ltd (000963.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.eastchinapharm.com
About Huadong Medicine Co., Ltd
Huadong Medicine Co., Ltd produces and sells various pharmaceutical products in China. It offers Chinese patent drugs, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, medical cosmetology, and antibiotic drugs, as well as medical equipment. The company's products include gastrointestinal agents, APIs, and other products. It also engages in the production and management of traditional Chinese and western raw medicines and preparations, and health care products; wholesale of TCM materials, TCM decoction pieces, chemical preparations, etc.; warehousing and storage business; and research, development, production, and sale of aesthetic medicine products. Huadong Medicine Co., Ltd was founded in 1993 and is headquartered in Hangzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.39B | 37.71B | 34.56B | 33.68B | 35.45B | 30.66B | 27.83B | 25.38B | 21.73B | 18.95B | 16.72B | 14.58B | 11.13B | 8.97B | 7.82B | 6.02B | 4.85B | 3.94B | 3.48B | 2.88B | 2.33B | 2.07B | 1.89B | 1.62B | 1.25B | 1.14B | 981.13M | 669.74M |
| Cost of Revenue | 27.85B | 25.68B | 23.96B | 22.55B | 24.09B | 21.77B | 20.56B | 19.22B | 16.52B | 14.78B | 13.34B | 11.73B | 8.95B | 7.29B | 6.26B | 4.85B | 3.81B | 3.17B | 2.86B | 2.39B | 1.95B | 1.75B | 1.58B | 1.34B | 1.03B | 948.75M | 830.39M | 604.31M |
| Gross Profit | 12.54B | 12.03B | 10.61B | 11.13B | 11.36B | 8.89B | 7.27B | 6.16B | 5.21B | 4.16B | 3.38B | 2.85B | 2.18B | 1.68B | 1.56B | 1.17B | 1.04B | 767.47M | 625.83M | 489.99M | 380.36M | 313.65M | 306.25M | 273.94M | 213.46M | 190.35M | 150.74M | 65.43M |
| Gross Profit Ratio | 31.04% | 31.90% | 30.69% | 33.05% | 32.05% | 28.99% | 26.12% | 24.27% | 23.98% | 21.98% | 20.20% | 19.54% | 19.63% | 18.76% | 19.98% | 19.36% | 21.41% | 19.47% | 17.96% | 17.00% | 16.35% | 15.18% | 16.23% | 16.93% | 17.13% | 16.71% | 15.36% | 9.77% |
| Research & Development | 1.27B | 1.02B | 979.64M | 926.73M | 1.07B | 706.04M | 461.75M | 264.09M | 217.74M | 172.54M | 160.85M | 125.23M | 101.90M | 89.08M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 466.41M | 524.06M | 515.37M | 465.59M | 536.10M | 369.58M | 267.75M | 222.80M | 227.11M | 224.78M | 169.50M | 136.07M | 96.46M | 68.69M | 247.00M | 242.16M | 212.79M | 200.32M | 171.78M | 172.44M | 146.61M | 101.52M | 88.60M | 91.59M | 63.80M | 46.28M | 37.32M | 22.94M |
| Selling & Marketing | 4.62B | 6.33B | 5.42B | 5.98B | 5.82B | 4.32B | 3.73B | 3.30B | 2.77B | 2.13B | 1.74B | 1.44B | 1.12B | 871.91M | 666.70M | 532.87M | 448.82M | 368.46M | 298.56M | 222.37M | 165.93M | 135.82M | 115.31M | 101.90M | 76.23M | 75.96M | 55.15M | 14.12M |
| SG&A | 7.81B | 6.86B | 5.94B | 6.45B | 6.36B | 4.69B | 4.00B | 3.52B | 3.00B | 2.35B | 1.91B | 1.57B | 1.22B | 940.60M | 913.70M | 775.03M | 661.61M | 568.78M | 470.35M | 394.82M | 312.54M | 237.34M | 203.92M | 193.49M | 140.03M | 122.24M | 92.47M | 37.06M |
| Other Expenses | 0.00 | 840.27M | 654.13M | 513.85M | 603.39M | 481.52M | -16.90M | 41.76M | 39.66M | 17.82M | 20.41M | 7.24M | 5.25M | 37.02M | 31.79M | 10.21M | 1.71M | 19.15M | 21.20M | 25.10M | 24.26M | 21.31M | -1.68M | 1.19M | 9.64M | 7.62M | 862.28K | 447.19K |
| Operating Expenses | 9.71B | 8.72B | 7.57B | 7.89B | 8.03B | 5.88B | 4.87B | 4.19B | 3.60B | 2.83B | 2.31B | 1.92B | 1.47B | 1.15B | 952.75M | 789.16M | 681.66M | 574.58M | 473.67M | 397.17M | 313.86M | 240.86M | 207.67M | 197.26M | 141.75M | 123.92M | 94.42M | 38.35M |
| Cost & Expenses | 36.80B | 34.40B | 31.53B | 30.44B | 32.12B | 27.65B | 25.43B | 23.41B | 20.11B | 17.62B | 15.65B | 13.65B | 10.41B | 8.43B | 7.21B | 5.64B | 4.50B | 3.75B | 3.33B | 2.79B | 2.26B | 1.99B | 1.79B | 1.54B | 1.17B | 1.07B | 924.81M | 642.66M |
| Interest Income | 94.05M | 103.35M | 80.40M | 60.99M | 30.59M | 35.31M | 31.88M | 28.90M | 9.64M | 8.51M | 7.72M | 6.55M | 8.70M | 5.45M | 0.00 | -0.26 | -0.17 | 7.48M | 7.74M | 5.94M | 6.10M | 2.99M | 9.80M | 7.18M | -0.55 | -0.44 | -0.31 | -0.82 |
| Interest Expense | 144.20M | 125.10M | 72.50M | 68.64M | 107.19M | 114.94M | 74.47M | 97.14M | 194.09M | 150.08M | 128.11M | 137.03M | 117.54M | 65.20M | 51.08M | 68.00M | 55.34M | 45.64M | 41.25M | 31.82M | 21.79M | 17.98M | 18.06M | 16.76M | 15.13M | 19.19M | 15.26M | 14.44M |
| Depreciation & Amortization | 818.35M | 711.31M | 596.36M | 439.55M | 411.23M | 327.14M | 277.40M | 215.53M | 158.85M | 134.53M | 119.02M | 98.74M | 84.67M | 71.97M | 60.64M | 45.59M | 44.92M | 44.64M | 41.37M | 34.19M | 31.51M | 24.38M | 13.59M | 12.70M | 10.67M | 6.50M | 11.95M | 12.88M |
| EBITDA | 4.39B | 4.00B | 3.58B | 3.99B | 3.99B | 3.20B | 2.67B | 2.11B | 1.60B | 1.33B | 1.08B | 902.13M | 710.58M | 579.45M | 672.28M | 421.49M | 402.94M | 261.99M | 223.87M | 163.53M | 127.04M | 121.96M | 126.22M | 96.98M | 82.38M | 68.05M | 56.32M | 27.08M |
| EBITDA Ratio | 10.87% | 10.33% | 10.27% | 10.86% | 10.98% | 10.94% | 9.69% | 8.87% | 8.33% | 7.85% | 7.29% | 7.14% | 7.46% | 7.34% | 8.97% | 7.63% | 8.30% | 6.59% | 6.37% | 5.58% | 5.46% | 5.90% | 6.69% | 6.03% | 6.64% | 6.40% | 5.74% | 4.04% |
| Operating Income | 3.59B | 3.06B | 2.86B | 3.48B | 3.40B | 2.91B | 2.34B | 1.86B | 1.38B | 1.16B | 924.84M | 782.67M | 610.44M | 461.70M | 536.78M | 273.00M | 303.20M | 170.93M | 139.75M | 90.77M | 72.43M | 80.35M | 97.05M | 69.97M | 55.58M | 53.64M | 44.38M | 14.20M |
| Operating Income Ratio | 8.88% | 8.12% | 8.26% | 10.32% | 9.58% | 9.49% | 8.41% | 7.31% | 6.36% | 6.11% | 5.53% | 5.37% | 5.48% | 5.15% | 6.86% | 4.54% | 6.25% | 4.34% | 4.01% | 3.15% | 3.11% | 3.89% | 5.14% | 4.33% | 4.46% | 4.71% | 4.52% | 2.12% |
| Total Other Income/Expenses | -121.85M | -30.33M | -28.18M | -23.18M | 73.22M | -55.73M | -31.69M | -42.36M | -159.97M | -137.94M | -103.96M | -130.13M | -95.67M | -25.16M | -22.05M | -93.60M | -53.53M | -659.15K | -34.65M | 4.03M | 1.30M | -749.82K | -2.48M | -2.45M | 7.11M | -8.09M | -1.29M | -722.70K |
| Income Before Tax | 3.47B | 3.03B | 2.83B | 3.45B | 3.47B | 2.87B | 2.32B | 1.88B | 1.42B | 1.17B | 942.29M | 787.52M | 612.86M | 495.49M | 565.16M | 282.31M | 303.97M | 169.37M | 139.23M | 94.80M | 73.73M | 79.60M | 94.57M | 68.46M | 62.69M | 59.23M | 43.09M | 13.48M |
| Income Before Tax Ratio | 8.58% | 8.04% | 8.18% | 10.25% | 9.79% | 9.37% | 8.35% | 7.42% | 6.54% | 6.19% | 5.64% | 5.40% | 5.51% | 5.52% | 7.22% | 4.69% | 6.26% | 4.30% | 4.00% | 3.29% | 3.17% | 3.85% | 5.01% | 4.23% | 5.03% | 5.20% | 4.39% | 2.01% |
| Income Tax Expense | 619.59M | 498.50M | 488.91M | 543.67M | 544.86M | 477.37M | 436.16M | 346.86M | 267.79M | 230.11M | 194.63M | 166.96M | 126.81M | 99.62M | 117.91M | 54.99M | 77.76M | 48.17M | 53.63M | 49.49M | 33.33M | 23.79M | 27.77M | 12.88M | 13.03M | 12.20M | 8.61M | 4.57M |
| Net Income | 2.84B | 2.50B | 2.30B | 2.82B | 2.81B | 2.27B | 1.78B | 1.45B | 1.10B | 756.67M | 574.98M | 469.93M | 381.48M | 317.31M | 378.42M | 168.61M | 173.16M | 83.35M | 67.31M | 30.58M | 30.58M | 46.53M | 57.48M | 45.91M | 40.35M | 40.25M | 30.38M | 8.91M |
| Net Income Ratio | 7.03% | 6.63% | 6.66% | 8.37% | 7.94% | 7.39% | 6.39% | 5.70% | 5.05% | 3.99% | 3.44% | 3.22% | 3.43% | 3.54% | 4.84% | 2.80% | 3.57% | 2.11% | 1.93% | 1.06% | 1.31% | 2.25% | 3.05% | 2.84% | 3.24% | 3.53% | 3.10% | 1.33% |
| EPS | 1.62 | 1.43 | 1.32 | 1.61 | 1.61 | 1.29 | 1.02 | 0.83 | 0.70 | 0.48 | 0.37 | 0.30 | 0.24 | 0.20 | 0.24 | 0.11 | 0.11 | 0.07 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.01 |
| EPS Diluted | 1.62 | 1.43 | 1.32 | 1.61 | 1.61 | 1.29 | 1.02 | 0.83 | 0.70 | 0.48 | 0.37 | 0.30 | 0.24 | 0.20 | 0.24 | 0.11 | 0.11 | 0.07 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.01 |
| Weighted Avg Shares Out | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.76B | 1.75B | 1.74B | 1.56B | 1.57B | 1.57B | 1.57B | 1.56B | 1.56B | 1.57B | 1.56B | 1.56B | 1.39B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B |
| Weighted Avg Shares Out (Dil) | 1.75B | 1.75B | 1.75B | 1.75B | 1.75B | 1.76B | 1.75B | 1.74B | 1.56B | 1.57B | 1.57B | 1.57B | 1.56B | 1.56B | 1.57B | 1.56B | 1.56B | 1.39B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B |
Source: https://incomestatements.info
Category: Stock Reports